Article
Cholesterol and APOE genotype interact to influence Alzheimer disease progression.
Neurology - 25 May 2004
Evans R M, Hui S, Perkins A, Lahiri D K, Poirier J, Farlow M R
Abstract excerpt
In this retrospective analysis of 443 Alzheimer disease (AD) patients from a 30-week tacrine trial, change in Alzheimer's Disease Assessment Scale score from baseline to final value was significantly associated with a total serum cholesterol/APOE genotype interaction. Disease progression in the no-APOE epsilon4 allele/high-cholesterol subgroup was greater than in the normal-cholesterol subgroups with or without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
